P3-200: Daily subcutaneous amifostine facilitates radiation dose escalation for poor risk unresectable stage III lung cancer

Gregory M. Videtic, Anand Desai, Chandana Reddy, Sujith Kalmadi, Tarek Mekhail
2007 Journal of Thoracic Oncology  
Daily subcutaneous amifostine facilitates radiation dose escalation for poor risk unresectable stage III lung cancer Videtic, Gregory M.; Desai, Anand; Reddy, Chandana; Kalmadi, Sujith; Mekhail, Tarek Cleveland Clinic, Cleveland, OH, USA Purpose: To report on the benefit of daily administration of subcutaneous amifostine to limit toxicity during dose-escalated radiotherapy (RT)
doi:10.1097/01.jto.0000284175.11066.c7 fatcat:fl2yoexdlbguhdxed7kvk3pdje